scispace - formally typeset
N

Nadja Hawwa Vissing

Researcher at Copenhagen University Hospital

Publications -  57
Citations -  3935

Nadja Hawwa Vissing is an academic researcher from Copenhagen University Hospital. The author has contributed to research in topics: Asthma & Medicine. The author has an hindex of 24, co-authored 46 publications receiving 3222 citations. Previous affiliations of Nadja Hawwa Vissing include University of Waterloo & Gentofte Hospital.

Papers
More filters
Journal ArticleDOI

Childhood Asthma after Bacterial Colonization of the Airway in Neonates

TL;DR: The prevalence of asthma and the reversibility of airway resistance after beta2-agonist administration at 5 years of age were significantly increased in the children colonized neonatally with these organisms as compared with the children without such colonization.
Journal ArticleDOI

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

Dominick E. Shaw, +56 more
TL;DR: U-BIOPRED is characterised by poor symptom control, increased comorbidity and airway inflammation, despite high levels of treatment, and is well suited to identify asthma phenotypes using the array of "omic" datasets that are at the core of this systems medicine approach.
Journal ArticleDOI

New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism.

Momoko Horikoshi, +174 more
- 01 Jan 2013 - 
TL;DR: The number of loci associated at genome-wide significance to 7, accounting for a similar proportion of variance as maternal smoking, are extended and highlight genetic links between fetal growth and postnatal growth and metabolism.
Journal ArticleDOI

Effect of Vitamin D3 Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring: A Randomized Clinical Trial

TL;DR: The use of 2800 IU/d of vitamin D3 during the third trimester of pregnancy compared with 400IU/d did not result in a statistically significant reduced risk of persistent wheeze in the offspring through age 3 years, and interpretation of the study is limited by a wide CI that includes a clinically important protective effect.